Sign In

Erik Lium

Chief Commercial Innovation Officer, Mount Sinai Health System; President, Mount Sinai Innovation Partners

Professional Background

Erik Lium is a distinguished leader in the fields of healthcare innovation and commercialization. Currently serving as the Executive Vice President and Chief Commercial Innovation Officer at the Mount Sinai Health System, Erik has dedicated his career to bridging the gap between scientific research and practical healthcare solutions. His current role allows him to leverage his extensive experience in product development, partnership building, and commercial strategy to drive innovations that can significantly improve patient care and health outcomes.

Before assuming his current leadership position, Erik held several key roles within Mount Sinai Health System, including President of Mount Sinai Innovation Partners, where he played a vital role in transforming cutting-edge research into workable industry solutions. Erik possesses a comprehensive understanding of the healthcare landscape, and his insights have been instrumental in fostering collaborations and creating an environment conducive to innovation.

Education and Achievements

Erik's academic credentials are as impressive as his professional endeavors. He earned his Doctor of Philosophy (Ph.D.) degree from the Integrated Program in Cellular, Molecular & Biophysical Studies at Columbia University College of Physicians and Surgeons, an institution renowned for its rigorous academic standards and groundbreaking research. Prior to this, Erik completed his Bachelor’s Degree in Biology at Gonzaga University, further solidifying his foundational knowledge in biological sciences.

Erik's educational background complements his practical experience, which includes several leadership positions with a focus on innovation in both academic and industry settings. His tenure at the University of California, San Francisco (UCSF) is particularly notable, where he served in various capacities, including Assistant Vice Chancellor of Research and the Office of Innovation, Technology & Alliances. In these roles, he was instrumental in fostering collaborations between the university and the industry, ensuring academic innovations translated into real-world applications.

As a member of various boards and committees, Erik's influence extends beyond Mount Sinai. He served as a member of the Board of Directors at RenalytixAI plc and participated as an observer on the Board of Directors at Amathus Therapeutics. He also contributed his expertise to the Investment Review Committee at Accelerate NY Seed Fund, where his insights have helped guide investment decisions in emerging technologies and life sciences startups.

Achievements

Throughout his career, Erik has consistently demonstrated a passion for innovation and a dedication to improving healthcare delivery. One of his significant achievements includes founding and leading LabVelocity, a company focused on expediting the commercialization of scientific innovations, which laid the groundwork for his future roles in healthcare and technology.

Erik's innovative approach to solving complex healthcare challenges has earned him respect and recognition in the healthcare community. His steadfast commitment to excellence, coupled with his vast experience in both academia and industry, positions him as a leading figure in the transformation of health technologies and integration into clinical practices.

tags':['healthcare innovation','commercial strategy','scientific research','medical technology','life sciences','leadership','biotechnology','Columbia University','Gonzaga University','Mount Sinai Health System','UCSF','innovation partnerships','clinical application','health outcomes','board of directors','investment review committee','healthcare solutions'],

questions

Erik Lium
Add to my network

Location

New York, New York, United States